NantKwest Launches Phase 1 Trial to Assess Investigational Cell Therapy for B-cell Lymphomas
News
NantKwest is launching the first-in-human Phase 1 clinical trial assessing the effects of its investigational CD19 t-haNK cell therapy in people with locally advanced B-cell lymphoma. The trial follows the ... Read more